US 8486391
Cancer treatment kits using antibodies to aminophospholipids
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 8486391 (Cancer treatment kits using antibodies to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K39/39558, A61K45/06